Related Experiment Video

Updated: Sep 30, 2026

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

A novel MPL point mutation resulting in thrombopoietin-independent activation

M Abe1, K Suzuki, O Inagaki

  • 1Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co Ltd, Tsukuba, Ibaraki, Japan.

Leukemia
|July 30, 2002
PubMed

Insights

A novel MPL mutation causes factor-independent cell growth by activating key signaling pathways. This discovery offers new insights into thrombopoietin receptor signaling and megakaryopoiesis regulation.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Hematopoiesis

Background:

  • Thrombopoietin (TPO) and its receptor (MPL) are crucial for megakaryopoiesis.
  • MPL is a member of the cytokine receptor superfamily.
  • Previously, constitutively active MPL mutants were artificially engineered.

Purpose of the Study:

  • To report a novel, spontaneously occurring MPL mutation.
  • To investigate the functional consequences of this mutation on cell growth and signaling.

Main Methods:

  • Analysis of MPL receptor mutations.
  • Ba/F3 cell culture for factor-independent growth assays.
  • Examination of intracellular signaling pathways (SHC-Ras-Raf-MAPK/JNK, JAK-STAT, PI3K-Akt-Bad).

Main Results:

  • A novel MPL mutation (Trp508Ser) in the intracellular domain was identified.
  • This mutation induced factor-independent growth of Ba/F3 cells.
  • The mutant MPL constitutively activated SHC-Ras-Raf-MAPK/JNK, JAK-STAT, and PI3K-Akt-Bad signaling pathways.

Conclusions:

  • Spontaneously occurring MPL mutations can lead to constitutive activation and aberrant cell growth.
  • The identified mutation provides a new model for studying MPL signaling in megakaryopoiesis.
  • Understanding these pathways is vital for potential therapeutic strategies in related disorders.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mutations02:27

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously during DNA replication or be induced by environmental factors. Mutations can be characterized in several ways: by whether and how they alter the amino acid sequence of the protein, by the scale of the DNA affected, and by whether they affect somatic or germline cells.Consequences of Point Mutations at the Molecular LevelMutations that affect a single nucleotide are called point mutations. When point mutations...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...